Two medications now dominate the conversation around medical weight management in the Philippines: Mounjaro and Wegovy. Both are weekly injectable medications. Both produce clinically meaningful weight loss. Both have generated enormous interest among Filipino patients, and both have generated an equal amount of confusion about which is the better choice. The question of Mounjaro vs Wegovy Philippines is genuinely important because the two medications, while related, are not

The Case for Tirzepatide, Properly Understood Tirzepatide is the active ingredient in Mounjaro, the branded medication produced by Eli Lilly. It is what clinicians call a dual receptor agonist, meaning it works on two gut hormone pathways at once. The first is the GLP-1 receptor (glucagon-like peptide-1). Activating this receptor slows gastric emptying, reduces appetite signalling to the brain, and improves the body's insulin response to meals. This is the same mechanism that